Filed: 8/14/2024ACC: 0001892688-24-000095
📋 What this filing means
DARWIN GLOBAL MANAGEMENT, LTD. filed this quarterly 13F‑HR report disclosing 9 equity positions with a total reported market value of $859.47M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
9
Positions
$859.47M
Total AUM (reported)
38.53M
Total Shares
Allocation by class
COM$351.79M40.9%
COM NEW$270.61M31.5%
COM PAR $.01$237.08M27.6%
Portfolio Concentration
Top 3$647.07M75.3%
4–10$212.41M24.7%
Top 3 weight
75.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 38.53M
Sole
Full voting authority
38.53M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole9
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings9
Rows:
CYTOKINETICS INC
SOLEShares4.58M
TypeSH
Market value$246.07M
28.63%
Sole
4.58M
Shared
0.00
None
0.00
INSMED INC
SOLEShares3.54M
TypeSH
Market value$237.08M
27.58%
Sole
3.54M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares2.08M
TypeSH
Market value$163.92M
19.07%
Sole
2.08M
Shared
0.00
None
0.00
GERON CORP
SOLEShares23.92M
TypeSH
Market value$106.18M
12.35%
Sole
23.92M
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares1.53M
TypeSH
Market value$68.77M
8.00%
Sole
1.53M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares325.14K
TypeSH
Market value$14.27M
1.66%
Sole
325.14K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares452.04K
TypeSH
Market value$10.27M
1.19%
Sole
452.04K
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares200K
TypeSH
Market value$8.11M
0.94%
Sole
200K
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares1.92M
TypeSH
Market value$4.81M
0.56%
Sole
1.92M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYTOKINETICS INCSOLE | COM NEW | 4.58M | SH | $246.07M 28.63% | 4.58M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 3.54M | SH | $237.08M 27.58% | 3.54M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 2.08M | SH | $163.92M 19.07% | 2.08M | 0.00 | 0.00 |
GERON CORPSOLE | COM | 23.92M | SH | $106.18M 12.35% | 23.92M | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 1.53M | SH | $68.77M 8.00% | 1.53M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 325.14K | SH | $14.27M 1.66% | 325.14K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 452.04K | SH | $10.27M 1.19% | 452.04K | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 200K | SH | $8.11M 0.94% | 200K | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 1.92M | SH | $4.81M 0.56% | 1.92M | 0.00 | 0.00 |